Ascendis Pharma
ASND
ASND
176 hedge funds and large institutions have $6.83B invested in Ascendis Pharma in 2021 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 83 increasing their positions, 53 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
4.32% less ownership
Funds ownership: 102.81% → 98.48% (-4.3%)
25% less capital invested
Capital invested by funds: $9.06B → $6.83B (-$2.23B)
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
Holders
176
Holding in Top 10
8
Calls
$18.1M
Puts
$18.4M
Top Buyers
| 1 | +$70.5M | |
| 2 | +$69.9M | |
| 3 | +$36M | |
| 4 |
SCM
Spyglass Capital Management
San Francisco,
California
|
+$34.7M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$33M |
Top Sellers
| 1 | -$300M | |
| 2 | -$199M | |
| 3 | -$75.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$26.4M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$17.2M |